Global Cancer Coalition Seeks To Increase Access To Medicines In LLMICs
Members Include Medicines Patent Pool, Teva And Generics Industry Body IGBA
Executive Summary
The Union for International Cancer Control has established the Access to Oncology Medicines Coalition to facilitate access to cancer drugs in low and lower-middle-income countries.
You may also be interested in...
IGBA Seeks To Underline Value And Access
Speaking with Generics Bulletin at the IGBA’s annual conference in February, chair Jonathan Kimball explained how the association is conveying the value of generics and biosimilars to international industry stakeholders.
Jonathan Kimball Named IGBA Chair For 2023
The IGBA chair passes to Jonathan Kimball. He will head the global off-patent industry organization as it steps up its activities in global policy.
Negotiators Prioritize Generic And Biosimilar Oncology Medicines Over Newer Drugs
The Union for International Cancer Control and the World Health Organization are prioritizing off-patent drugs in their efforts to facilitate oncology medicine access in developing nations.